Background and Objectives We conducted a systematic review and meta-analysis to
evaluate the relationship between no evidence of disease activity (NEDA) and no long-term …

A personalized approach is strongly advocated for treatment selection in Multiple Sclerosis
patients due to the high number of available drugs. Machine learning methods proved to be …

Background The assessment of treatment response is a crucial step for patients with
relapsing-remitting multiple sclerosis on disease-modifying therapies (DMTs). We explored …

Introduction Multiple sclerosis (MS) is more prevalent in women than in men. The sex of the
patient, and pregnancy, are reported to be associated with the clinical features of MS. The …

Introduction It is important to confirm the effectiveness and tolerability of disease-modifying
treatments for relapsing–remitting multiple sclerosis (RRMS) in real-world treatment settings …

Background Multiple sclerosis (MS) is a chronic autoimmune disease with huge
heterogeneity in terms of clinical course, disease severity and treatment response. The need …

Introduction: It is important to confirm the effectiveness and tolerability of disease-modifying
treatments for relapsing–remitting multiple sclerosis (RRMS) in real-world treatment settings …